Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
Clinical trial NCT05969496 · RECRUITING
Trial details
- NCT number
- NCT05969496
- Sponsor
- University of Colorado, Denver
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-04
- Primary completion
- 2026-11-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.